Form EFFECT Cidara Therapeutics,
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | January 9, 2026 |
| Accession Number: | 0001193125-26-005780 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Civil Society Organizations Call on Correctional Service Canada to Restore Access to Mental Health Medications
- Bitcoin Price Prediction Amid $100M Liquidations – Where Could the Next Crypto to Explode in 2026 Come From?
- Air Canada Unveils Top 30 Contenders for 2026 Best New Restaurants and marks 25 Years of Food Worth Flying For
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share